129042-20-2

Upstream product

• 129042-15-5 Acetic acid 4-oxo-1-phenyl-3,4,6,7-tetrahydro-[1,4]diazepino[6,7,1-hi]indol-3-yl ester 
• 496-15-1 1-indoline 
• 29813-79-4 7-benzoyl-1-bromoacetyl-2,3-dihydro-indole 
• 33244-57-4 7-benzoyl-1H-indoline 
• 100-47-0 benzonitrile 
• 129042-12-2 2-Oxy-1-phenyl-6,7-dihydro-3H-[1,4]diazepino[6,7,1-hi]indol-4-one 

Downstream Products

• 1026903-25-2 Methanesulfonic acid 4-oxo-1-phenyl-3,4,6,7-tetrahydro-[1,4]diazepino[6,7,1-hi]indol-3-yl ester 
• 129041-57-2 (3S)-1-phenyl-3-<(S)-phenylalanyl>amino-3,4,5,7-tetrahydropyrrolo<3,2,1-jk><1,4>benzodiazepin-4(3H)-one 
• 129041-56-1 (3R)-1-phenyl-3-<(S)-phenylalanyl>amino-3,4,5,7-tetrahydropyrrolo<3,2,1-jk><1,4>benzodiazepin-4(3H)-one 
• 126252-49-1 (3S)-3-amino-5-phenyl-3,4,6,7-tetrahydropyrrolo<3,2,1-jk><1,4>benzodiazepin-4(3H)-one 
• 126252-50-4 (3R)-3-amino-5-phenyl-3,4,6,7-tetrahydropyrrolo<3,2,1-jk><1,4>benzodiazepin-4(3H)-one 
• 126149-54-0 (RS)-3-amino-5-phenyl-3,4,6,7,-tetrahydropyrrolo<3,2,1-jk><1,4>benzodiazepin-4(3H)-one 

Relevant academic research and scientific papers

Studies on a novel, potent and orally effective cholecystokinin A antagonist, FK-480. Synthesis and structure-activity relationships of FK-480 and related compounds

We prepared various novel tricyclic 1,4-benzodiazepine derivatives as cholecystokinin (CCK) A antagonists, which were evaluated preliminarily for inhibition of 125I-CCK-8 binding to rat pancreatic membranes in vitro and inhibiting effect on CCK